Int J Radiat Oncol Biol Phys 2011;81:e735–41.43. Clin Colorectal Cancer 2014;13:192–8.95.
Yothers G, O’Connell MJ, Allegra CJ, et al.
Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials. J Clin Oncol 2010;28:3521.63. Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. Ann Surg 2007;246:215–21.39. Aparicio T, Gargot D, Teillet L, et al. J Natl Compr Canc Netw 2013;11:1494-502.25. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. Regorafenib dose optimization study (ReDOS): Randomized phase II trial to evaluate dosing strategies for regorafenib in refractory metastatic colorectal cancer (mCRC): an ACCRU Network study [abstract]. Once treatments meant to halt colon cancer are no longer working, and is considered terminal, it is important to know what to expect. Figer A, Perez-Staub N, Carola E, et al. Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer. Balducci L. Frailty: a common pathway in aging and cancer. Common Tests and Diagnoses for Cancer among Seniors It sounds cruel, but as i work self employed and not in a financial position to stop work, i have to make best use of my time with dad.
Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial.
Soubeyran P, Bellera C, Goyard J, et al. Here are some of the most common symptoms of prostate cancer:Understand the causes, risk factors and symptoms of not only prostate cancer, but Gastrointestinal cancer is a broad term used to encompass all cancers of the gastrointestinal tract (digestive system). Cancer 2008;113:3459–66.110. J Clin Oncol 2008;26:1443–51.79. Daste A, Domblides C, Gross-Goupil M, et al. Family history of colon cancer. Shalaby M, Di Lorenzo N, Franceschilli L, et al. J Clin Oncol 2011;29:1465–71.62. Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial. Here are the most recognizable symptoms of stomach cancer:The ability to recognize these symptoms early on will increase the likelihood of the individual recovering from the disease.Breast cancer is a mass of abnormal cells in the breast that has the potential to spread to the surrounding tissue. Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? A 34-year-old member asked: What happens when you leave colon cancer untreated and it begins to bleed? Ruff P, Van Cutsem E, Lakomy R, et al.
You're more likely to develop colon cancer if you have a blood relative who has had the disease. Lancet 2000;356:968–74.31. While this is uncommon, it’s crucial that seniors know the risk factors of cancer, and get themselves screened regularly.Colon cancer is the formation of abnormal cells in the colon or rectum. Finding the perfect senior care community is only part of making your loved one’s senior living transition smooth. Vijayvergia N, Li T, Wong YN, et al. Twelves C, Wong A, Nowacki MP, et al.
McCleary NJ, Meyerhardt JA, Green E, et al. The exact cause of colon cancer in the elderly is unknown, but factors such as heredity, smoking, and previous polyp detection can increase the potential for a senior to develop the disease.
Van Cutsem E, Rivera F, Berry S, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. Yothers G, O’Connell MJ, Allegra CJ, et al. J Surg Oncol 2009;100:364–71.37. Gryfe R, Kim H, Hsieh ET, et al.
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Oncology 2010;78:329–39.86. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial. Adam R, Frilling A, Elias D, et al.
McCleary NJ, Meyerhardt JA, Green E, et al. Shahir MA, Lemmens VE, van de Poll-Franse LV, et al. Oncologist 2012;17:339–45.94.
About 50 percent of individuals diagnosed with prostate cancer are over the age of 65. J Clin Oncol 2012;30:2624–34.71. Physical performance and subsequent disability and survival in older adults with malignancy: results from the health, aging and body composition study. Colon cancer is the formation of abnormal cells in the colon or rectum. Haller DG, Tabernero J, Maroun J, et al.
de Liguori Carino N, van Leeuwen BL, Ghaneh P, et al. Twelves C, Wong A, Nowacki MP, et al.